Manchester Capital Management LLC

Position in ADIL — Adial Pharmaceuticals, Inc.

CIK 1393389 MANCHESTER, VT

Position in ADIL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$4,922

+$1,480 QoQ

Shares Held

1,923

0.0% QoQ

Ownership

0.073%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Manchester Capital Management LLC holds $805,024 across 28 Biotechnology names. ADIL ranks #13 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REPL	Replimune Group, Inc.	25,675	$284,222
2	VRTX	Vertex Pharmaceuticals Inc / Ma	391	$194,221
3	INSM	INSMED Inc	1,033	$110,138
4	RPRX	Royalty Pharma plc	694	$38,912
5	REGN	Regeneron Pharmaceuticals, Inc.	47	$29,306
6	ABVX	Abivax S.A.	200	$26,652
7	ALNY	Alnylam Pharmaceuticals, Inc.	83	$24,985
8	MRNA	Moderna, Inc.	321	$22,479

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,922	1,923	0.0%	Shares	Sole	2026-08-13
2026-03-31	$3,442	1,923	-96.0%	Shares	Sole	2026-05-11
2025-12-31	$10,581	48,097	0.0%	Shares	Sole	2026-02-11
2025-09-30	$16,833	48,097	0.0%	Shares	Sole	2025-11-14
2025-06-30	$14,429	48,097	0.0%	Shares	Sole	2025-08-12
2025-03-31	$30,301	48,097	0.0%	Shares	Sole	2025-05-09
2024-12-31	$48,577	48,097	0.0%	Shares	Sole	2025-01-30
2024-09-30	$48,097	48,097	0.0%	Shares	Sole	2024-11-05
2024-06-30	$55,311	48,097	0.0%	Shares	Sole	2024-08-08
2024-03-31	$63,969	48,097	0.0%	Shares	Sole	2024-05-06
2023-12-31	$89,460	48,097	0.0%	Shares	Sole	2024-02-08
2023-09-30	$133,709	48,097	-96.0%	Shares	Sole	2023-11-09
2023-06-30	$252,514	1,202,452	0.0%	Shares	Sole	2023-08-14
2023-03-31	$420,858	1,202,452	—	Shares	Sole	2023-05-09
No filing history on record for this holder in this stock.